EMR Messaging Woes (4.11.2025)
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on RheumNow.com
Read Article
2nd Opinions in Rheumatology
https://t.co/R4CjJHEaL4 https://t.co/0quDwdANyU
Dr. John Cush @RheumNow( View Tweet )
Summary of the updated BSR Axial Spondyloarthritis for biological and targeted synthetic DMARD guidelines 2025 @RheumatologyUK #axialspondyloarthritis
Full paper available at:
https://t.co/LytDiHjawi https://t.co/iaHzD1BQRe
Links:
Antoni Chan MD (Prof) @synovialjoints( View Tweet )
📢Calling all paediatrics! #BSR25 is almost here - Check out our top paediatric highlights from a packed Annual Conference programme 🔗Read our latest blog now: https://t.co/8uJMiqg2fW https://t.co/PAASNk3ZuF
Links:
BSR @RheumatologyUK( View Tweet )
Prof Ian Giles will be covering a range of topics at this year's Rheumapreg Conference such as how immunologic changes and placental dysfunction cause adverse outcomes in rheumatic disease pregnancies.
View the full prgramme and learn more: https://t.co/tjiycjKJ8i https://t.co/FugHvtm8fY
BSR @RheumatologyUK( View Tweet )
43 days to the Lupus Congress 2025 in Toronto 🦋...see you soon!
Abstract Sessions, Poster Tour Presentations, Plenary Sessions, Scientific Sessions, Debate Sessions, Patient Sessions, Fishbowl Discussion, and GALA DINNER on May 23!!!
@LupusCongress https://t.co/MaWjyofnIz
Zahi Touma, MD, PhD @ZahiTouma( View Tweet )
ACP: Best Practice Advice on Cannabis or Cannabinoids Use for Chronic Noncancer Pain
The American College of Physicians published a best practice advisory on cannabis or cannabinoids in the Annals of Internal Medicine.
https://t.co/5OxXvCOVtD https://t.co/l5PaDRHZQh
Dr. John Cush @RheumNow( View Tweet )
An Epidural Letdown (4.4.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on https://t.co/V10S4oVFsv.
https://t.co/YDxQWukJ5U https://t.co/Pr7tG5rU0R
Dr. John Cush @RheumNow( View Tweet )
Patient Education handout on Carpal Tunnel Syndrome https://t.co/NMRKGeE7Po https://t.co/LYnTlfJBcZ
Links:
Dr. John Cush @RheumNow( View Tweet )
#RheumTwitter—Heading to the highly anticipated State-of-the-Art Clinical Symposium (SOTA), April 4-6, in Chicago? Share your meeting experience on social & be sure to include #SOTA25 in your posts. We can’t wait to see you there! https://t.co/HZTZUm2UfG
American College of Rheumatology @ACRheum( View Tweet )
🎉 Today's Annual Scientific Conference kicked off with The CARRA Registry Retreat! The retreat brought together physician-PIs, research coordinators, research managers and patients/caregivers involved with the CARRA Registry. 💙 #CARRA2025 #pedsrheum https://t.co/GYYHAjsIdK
CARRA @carrainc( View Tweet )
An Epidural Letdown (4.4.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
Read Article
Congrates to Arthritis Research & Therapy on their 25th anniversay - 25 years of research and therapy in arthritis. Started 25 yrs ago by Drs. Peter Lipsky and Ravinder Maini https://t.co/4GFj9qktzr https://t.co/bUz0Ms0y6M
Dr. John Cush @RheumNow( View Tweet )
✅ IF YOU ARE LIVING WITH #LUPUS, you can now try #SLAKE, the ONLINE DIGITAL research tool for assessing your ESSENTIAL KNOWLEDGE about #SLE in English, German, Arabic, Spanish, Chinese, Français, Hindi, Indonesian, Dutch, etc... using the following LINK: https://t.co/nSCdBBMEcx https://t.co/PBAPkGynjP
Links:
Laurent ARNAUD @Lupusreference( View Tweet )
Patient Education handout on Raynaud’s Phenomenon https://t.co/Ug2MmtexgU https://t.co/kk9Klxhl8x
Dr. John Cush @RheumNow( View Tweet )
Patient Education handout on Carpal Tunnel Syndrome https://t.co/QwgZ8Jr7GQ https://t.co/wtg324nzlo
Links:
Dr. John Cush @RheumNow( View Tweet )
Patient Education handout on Raynaud’s Phenomenon https://t.co/cm77mmmPSi https://t.co/GimQXHBdpp
Dr. John Cush @RheumNow( View Tweet )
“Medicine is a science of uncertainty and an art of probability.” - Sir William Osler https://t.co/SQH3JZcDfv
Dr. John Cush @RheumNow( View Tweet )
Autoimmune Disease Impact Report
Integrated Benefit Institute, a nonprofit independent research organization, has published its 2025 Autoimmune Disease Impact Report, which examines the health and productivity impacts of five prevalent and costly autoimmune conditions: https://t.co/x3l9HIDul8
Dr. John Cush @RheumNow( View Tweet )
Rheums! Have a rheumatology question or case for Dr.Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
https://t.co/VkPL7thzo8 https://t.co/h85iF6tIVk
Dr. John Cush @RheumNow( View Tweet )
Full read review on inflammatory myositis (Patient or med student level knowlegdge) Epidemiology
Risk Factors
Prognosis
Sxs, Dx, Differential Dx
Treatment
Complications
Myositis Guidelines
https://t.co/s0LtHyYeuS https://t.co/lMEpMIotSP
Links:
Dr. John Cush @RheumNow( View Tweet )
Missed RheumNow Live but still want the great coverage? For the first time ever, https://t.co/4UQlqwujiR 2025 is Available On Demand!
✔️ STEP Talks from top rheumatologists
✔️ Lectures on the biggest clinical challenges
✔️ Speaker slides and handouts you’ll use
Non-CME, https://t.co/lns8EQBZjw
Links:
Dr. John Cush @RheumNow( View Tweet )
Worse Outcomes in HLA-B27+ JIA
Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term outcomes, including lower rates of drug-free remission, in a prospective Scandinavian study.
https://t.co/VEKqHvO1qw https://t.co/49y0JQL0Gr
Dr. John Cush @RheumNow( View Tweet )
Cancer Survival with TNF Inhibitors (3.28.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Read Article
Autoimmune Disease Impact Report
Integrated Benefit Institute, a nonprofit independent research organization, has published its 2025 Autoimmune Disease Impact Report, which examines the health and productivity impacts of five prevalent and costly autoimmune conditions: https://t.co/TfXZti5NN3
Dr. John Cush @RheumNow( View Tweet )
Recent Blogs
